清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Overexpression of ULK1 Represents a Potential Diagnostic Marker for Clear Cell Renal Carcinoma and the Antitumor Effects of SBI-0206965

作者
Jun Lü,Ling Zhu,Luoping Zheng,Qiang Cui,Hehuan Zhu,Hu Zhao,Zhouji Shen,Huiyue Dong,Shushang Chen,Weizhen Wu,Ming Jen Tan
出处
期刊:EBioMedicine [Elsevier BV]
卷期号:34: 85-93 被引量:82
标识
DOI:10.1016/j.ebiom.2018.07.034
摘要

BACKGROUND: Uncoordinated 51-like kinase 1 (ULK1) plays a vital role in autophagy. ULK1 dysregulation has recently been found in several human cancers. METHODS: mRNA expression levels of ULK1 and clinical information were analysed from The Cancer Genome Atlas data. ULK1 expression levels were verified in 36 paired fresh ccRCC tissue specimens by western blot analysis. Expression of ULK1 was knockdown by shRNA lentivirus. ULK1 activity was inhibited by SBI-0206965. The effect of inhibition of ULK1 was measured by detecting the apoptotic rate, autophagy, and the ratio of ROS and NADPH. The efficacy of SBI-0206965 in vivo was assessed by the murine xenograft model. FINDINGS: ULK1 mRNA expression was significantly upregulated in clear cell renal cell carcinoma (ccRCC) and overexpression of ULK1 correlated with poor outcomes. We found that ULK1 was highly expressed in 66.7% of ccRCC tumours (p < 0·05). Knockdown of ULK1 and selective inhibition of ULK1 by SBI-0206965 induced cell apoptosis in ccRCC cells. We demonstrated that SBI-0206965 triggered apoptosis by preventing autophagy and pentose phosphate pathway (PPP) flux. Furthermore, blocking the kinase activity of ULK1 with SBI-0206965 resulted in a level of anticancer effect in vivo. INTERPRETATION: Taken together, our results suggested that ULK1 was upregulated in ccRCC tumours and may be a potential therapeutic target. Therefore, SBI-0206965 should be further considered as an anti-ccRCC agent. FUND: This work was supported in part by The National Natural Science Foundation of China (No. 81570748) and Natural Science Foundation of Fujian Province (No. 2018J01345, 2017XQ1194).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ybcy完成签到,获得积分10
1秒前
wrxaa完成签到,获得积分10
2秒前
4秒前
大力的映天完成签到,获得积分10
5秒前
潘润朗完成签到,获得积分10
5秒前
qimoqi完成签到,获得积分10
6秒前
ln完成签到,获得积分10
6秒前
莫忘初心完成签到,获得积分10
6秒前
7秒前
7秒前
搜集达人的应助被TingtingGZ采纳,获得10
9秒前
友好语风完成签到,获得积分10
11秒前
NiaoJiang完成签到,获得积分10
11秒前
Wtony完成签到 ,获得积分0
11秒前
INC完成签到,获得积分10
13秒前
迷人的危险最值钱完成签到,获得积分10
15秒前
美好的初翠完成签到,获得积分10
16秒前
July完成签到,获得积分10
16秒前
kkdg完成签到,获得积分10
18秒前
邓大瓜完成签到,获得积分10
18秒前
脑洞疼的应助被369ninja采纳,获得10
18秒前
MaidLingYan完成签到,获得积分10
22秒前
22秒前
22秒前
DrPika完成签到,获得积分10
22秒前
KKDG完成签到,获得积分10
23秒前
熊熊熊完成签到,获得积分10
23秒前
23秒前
ZHZ完成签到,获得积分10
24秒前
25秒前
聪明的羿完成签到,获得积分10
26秒前
joker000717完成签到,获得积分10
27秒前
TingtingGZ发布了新的文献求助10
27秒前
千帆完成签到,获得积分10
27秒前
Zilaap完成签到,获得积分10
28秒前
完美世界的应助被科研通管家采纳,获得10
28秒前
花开富贵完成签到,获得积分10
28秒前
28秒前
28秒前
丁大胜完成签到,获得积分10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173194
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780496
捐赠科研通 7767299
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476688